Antilymphocyte Serum [clinicaltrials_resource:49f1b34e227936be908f6e1129577ee9]
Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders [clinicaltrials:NCT00000597]clinicaltrials:NCT00001626Medical Treatment for Diamond Blackfan Anemia [clinicaltrials:NCT00001749]A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome [clinicaltrials:NCT00001839]Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission [clinicaltrials:NCT00002534]clinicaltrials:NCT00002718Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00002809]Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003270]clinicaltrials:NCT00003335clinicaltrials:NCT00003336Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003396]Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003398]Antiviral Therapy Plus Either Peripheral Stem Cell or Umbilical Cord Blood Transplantation in Treating Patients Who Are HIV Positive and Have Hematologic Cancer [clinicaltrials:NCT00003435]Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Melanoma [clinicaltrials:NCT00003552]clinicaltrials:NCT00003553Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003661]Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Other Hematologic or Metabolic Diseases [clinicaltrials:NCT00003662]clinicaltrials:NCT00003816Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease [clinicaltrials:NCT00003913]clinicaltrials:NCT00004145Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00004208]Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00004255]Phase II Study of Bone Marrow Transplantation Using Related Donors in Patients With Aplastic Anemia [clinicaltrials:NCT00004323]Phase III Randomized Study of Cyclophosphamide With or Without Antithymocyte Globulin Before Bone Marrow Transplantation in Patients With Aplastic Anemia [clinicaltrials:NCT00004474]Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00004904]Removal of T Cells to Prevent Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00005641]Bone Marrow Transplantation in Treating Patients With Severe Aplastic Anemia or Rejection of Previous Bone Marrow Transplant [clinicaltrials:NCT00005852]Biological Therapy in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005853]Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders [clinicaltrials:NCT00005893]Phase I/II Study of Total Body Irradiation, Cyclophosphamide, and Fludarabine Followed by Alternate Donor Hematopoietic Cell Transplantation in Patients With Fanconi's Anemia [clinicaltrials:NCT00005898]clinicaltrials:NCT00005937Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies [clinicaltrials:NCT00006054]Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases [clinicaltrials:NCT00006055]Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders [clinicaltrials:NCT00006056]clinicaltrials:NCT00006379Bone Marrow Transplantation in Treating Patients With Leukemia [clinicaltrials:NCT00006451]Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [clinicaltrials:NCT00008307]clinicaltrials:NCT00010335Phase I Pilot Study of Total-Body Irradiation, Anti-Thymocyte Globulin and Cyclophosphamide Followed By Syngeneic or Autologous Peripheral Blood Stem Cell Transplantation in Patients With Multiple Sclerosis [clinicaltrials:NCT00014755]clinicaltrials:NCT00016419
intervention browse [clinicaltrials_vocabulary:intervention-browse]
Antilymphocyte Serum [clinicaltrials_resource:49f1b34e227936be908f6e1129577ee9]
Bio2RDF identifier
49f1b34e227936be908f6e1129577ee9
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:49f1b34e227936be908f6e1129577ee9
identifier
clinicaltrials_resource:49f1b34e227936be908f6e1129577ee9
title
Antilymphocyte Serum
@en
type
label
Antilymphocyte Serum [clinicaltrials_resource:49f1b34e227936be908f6e1129577ee9]
@en